Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 12/20 | 0.49 |
| ▸ | EHMT1 | Q9H9B1 | 11/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CCR4 | P51679 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5457407 | 0.84 | EHMT2 (0.53) | EHMT2EHMT1MAPTSMN1; SMN2LMNA | |
| SCHEMBL5032290 | 0.82 | MAPT (0.50) | EHMT2EHMT1MAPTSMN1; SMN2NPSR1 | |
| Citric Acid SCHEMBL6016965 | 0.77 | EHMT2 (0.43) | EHMT2EHMT1MAPTLMNAALDH1A1 | |
| SCHEMBL4837987 | 0.77 | EHMT2 (0.50) | EHMT2EHMT1MAPTSMN1; SMN2KMT2A | |
| SCHEMBL4839209 | 0.77 | EHMT2 (0.50) | EHMT2EHMT1MAPTSMN1; SMN2LMNA | |
| SCHEMBL5420636 | 0.76 | EHMT2 (0.44) | EHMT2EHMT1MAPTNPSR1HTT | |
| SCHEMBL5030769 | 0.75 | MAPT (0.50) | EHMT2EHMT1MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL6016637 | 0.73 | EHMT2 (0.48) | EHMT2EHMT1KDM1ARCOR1 | |
| SCHEMBL6017083 | 0.72 | BCL6 (0.47) | EHMT2EHMT1KDM1ARCOR1 | |
| SCHEMBL4832215 | 0.71 | EHMT2 (0.44) | EHMT2EHMT1MAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332489-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | EHMT2 2905/4885EHMT1 2811/4885MAPT 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.